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ew Methods for Risk
tratification in Patients
fter Myocardial Infarction
utonomic Control
nd Substrate Sensitivity*
eter Sleight, MD, FACC
xford, United Kingdom
isk stratification after myocardial infarction (MI) is im-
ortant to select greater-risk patients who warrant more
ggressive strategies for prevention of future serious events
uch as reinfarction or sudden death. The results of the
ADIT II (Multicenter Automatic Defibrillator Implan-
ation) trial (1) suggested that patients with an ejection
raction (EF) 30% benefited from an implanted cardiac
efibrillator. However, this costly procedure has not been
niversally adopted (2).
See pages 2275 and 2285
In this issue of the Journal, 2 important papers address
ifferent aspects of risk stratification after MI but in
ontrasting patient populations. The Canadian study by
xner et al. (3) from 6 hospitals in the Province of Alberta
i.e., REFINE [Risk Estimation Following Infarction,
on-invasive Evaluation] study) looked at the role of
-wave alternans (TWA) and averaged QRS duration (as
arkers of an arrhythmic substrate), together with markers
f autonomic tone (baroreflex sensitivity [BRS], heart rate
ariability [HRV], and heart rate turbulence [HRT]) in 322
atients who had survived an MI but with left ventricular
LV) impairment (an EF of 40%, measured in the first
8 h, or 50% measured after 48 h). The 322 eligible
atients (of 5,699 MI patients screened) were followed up
or 4 years at hospitals where the majority of MI patients
ere cared for by cardiologists; they received appropriate
edical therapy with antiplatelet agents (approximately
5%), beta-blockers (90%), angiotensin-converting enzyme
nhibitors (90%), and statins (87%). Approximately one-
hird of the patients received revascularization within 24 h
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or thea
merican College of Cardiology.
From the University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.nd approximately 10% underwent later revascularization.
his aggressive treatment might partly account for the rela-
ively low percentage of patients who met the entry criteria for
educed EF. To avoid bias caused by alteration in treatment,
he results of the initial testing were withheld from their
esponsible physicians.
Markers of poor autonomic control plus an arrhythmic
ubstrate identified patients at increased risk of sudden
eath (and of all cause death). None of these markers
eliably identified future high-risk patients when tested in
he first 2 to 4 weeks after MI but did so when retested 10
eeks or more after MI, when the combination of a
eceptive substrate, together with impaired autonomic con-
rol, identified a group (20% of the 322) who had a relative
isk of 5.2 times that of patients without these markers (p
.001).
In contrast, in a simpler Italian study from a single center,
e Ferrari et al. (4) examined the value of BRS testing
lone, at 4 to 6 weeks after the MI, in stratifying risk over
years in 244 consecutive ST-segment elevation myocardial
nfarction (STEMI) patients with better preserved cardiac
unction (EF of 35%, average 54  8%), selected from
68 consecutive survivors with STEMI. In this different
opulation with relatively preserved LV function, depressed
RS was present in 14% but identified patients with a
elative risk of cardiovascular mortality of 11.4, compared
ith those without impaired BRS (cardiovascular mortality
6% vs. 2.4% over 5 years). In this population with
reserved EF, EF itself was (unsurprisingly) not predictive.
hese results, from some of the same group that had earlier
erformed the ATRAMI (Autonomic Tone and Reflexes
fter Myocardial Infarction) study (5), extend the
TRAMI study findings to a longer follow-up (5 years vs.
1 months for the ATRAMI study).
Before discussing these important results in more detail,
t is necessary to comment on the methodological aspects,
hich differ importantly between the 2 studies with regard
o the autonomic markers chosen. Both studies used the
xford phenylephrine method (6,7). In brief, an intrave-
ous injection of this alpha-adrenergic agent constricts
ascular smooth muscle and increased arterial blood pressure
BP). This increased BP is sensed by the arterial barorecep-
ors and results in reflex slowing of the heart. Plotting the
ystolic pressures of consecutive beats (measured noninva-
ively from the finger by the Finapres machine [Ohmeda,
ouisville, Colorado]) against the reflex cardiac slowing
measured from the electrocardiogram as the following
ulse interval) results in a linear plot. The steepness of the
lope of this regression line in milliseconds per millimeter of
ercury (ms/mm Hg) gives an index of vagal response to
he increase in BP. This response is impaired with age and
ith hypertension (8) and several other disease states. In the
ast (and still persisting in 9 of 10 in a random survey of
urrent textbooks of physiology), it was believed that the
rterial baroreflex was concerned only with short-term
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Editorial Comment December 11, 2007:2291–3orrection of BP changes but had no influence on longer-
erm BP (9). Recent experiments by a number of investiga-
ors, such as Thrasher (10), have shown that the baroreflex
oes indeed influence long-term BP by sympathetically
ediated control of sodium excretion by the kidney. I have
ong advocated (11,12) that the older, erroneous view was a
esult of the misinterpretation of experiments on sino-aortic
enervated dogs, carried out by Cowley et al. (9). This
nfluence of impaired BRS in increasing longer-term BP
ight be another factor in worsening the prognosis, in
ddition to the loss of vagal protection against sudden
rrhythmic death (13).
In the ATRAMI study (5), it was found that a BRS value
f 3.1 ms/mm Hg was highly predictive of an adverse
rognosis after MI; this value was that used in the current
talian study (4) to dichotomize responses into impaired
RS and relatively preserved BRS. However, the Canadian
EFINE study (quoting the same ATRAMI study results)
sed a cutoff of6.1 ms/mm Hg. The reason for the choice
y the REFINE Investigators of a cutoff of 6.1 ms/mm Hg
s not clear, although these authors do quote Redwood et al.
14), who found that dichotomy values for a determined
ingle variable were not always applicable where that vari-
ble was used as one of a combination of risk factors.
owever, Redwood et al. (14) did find that HRV dichot-
my values (which are closely related to BRS) were little
ltered when combined with other factors. In my opinion,
his cutoff at 6.1 mm Hg is too high, because many elderly
ubjects will have a normal BRS around this level (8); this
hoice may account for their finding that another method,
lso related to BRS assessment (namely heart rate turbu-
ence), was marginally more predictive than conventional
RS in their study. The use of HRT measures the acceler-
tion of heart rate, which follows the BP decrease after an
ctopic beat, together with the subsequent deceleration as
P increases again (15). Less change (less turbulence) is
redictive of a poor prognosis. There have been few previ-
usly noted correlations of BRS and HRT in the same
opulations; it seems a pity, therefore, that the REFINE
tudy used an unconventional value for dichotomization of
RS. The developers of the HRTmethod acknowledge that
he arterial baroreflex is one of the important determinants
f HRT (16). The assessment of autonomic function is also
ighly dependent on environmental factors such as exercise
17) or arousal (18); comparisons should therefore be con-
ucted in the same steady state. Finally, one should add that
ll methods of assessing autonomic function are highly
ariable; it is therefore better to repeat these measurements
number of times in any patient to obtain an average value.
either of these studies reveals how many tests were done to
ssess BRS, HRT, or HRV. Furthermore, the Italian study
4) is confined to patients surviving STEMI with preserved
eft ventricular function, whereas it appears that the Cana-
ian study (3) encompasses both STEMI and non-STEMI
urvivors with impaired left ventricular function. sDespite these technical considerations, there is much to
e learned from these 2 studies. The REFINE study
howed (understandably) that a combination of an auto-
omic measure with a measure of cardiac vulnerability to
rrhythmia (TWA), in a higher-risk population with im-
aired LV function, gave better prognostic discrimination
han either measure alone. Their exercise protocol (testing
or TWA) omitted the immediately preceding dose of the
eta-blocker to obtain a faster heart rate response. However,
n an earlier study of the effects of beta-blockade on
xercising heart rate, we found persisting blunting of the
ate response even after a week or more without drug (19).
The REFINE study authors (3) acknowledge that their
ndings need to be validated in a larger population. In the
EFINE study, there were only 24 serious arrhythmic
vents. The finding that these tests were better long-term
redictors when measured after the acute phase after MI is
lso important, because most risk stratification is performed
n the acute (and unstable) phase. Another problem is that
he combined end point (autonomic substrate EF) was
resent in only 20% of the already highly selected 322
atients in this study.
The Italian study (4) is equally important because it
tratifies the risk of a group with well-preserved left ven-
ricular function, which is normally classed as low risk. In
his population, BRS 3 ms/mm Hg identified subgroups
ith markedly different risks, both in younger (65 years)
atients (relative risk 19.6, p  0.0002) and older patients
relative risk 7.2, p  0.02). Furthermore, the proportion of
he population with well-preserved left ventricular function
fter MI is larger than that of the REFINE study. But in
oth populations the survival curves based on these relatively
ew prognostic measures continued to diverge during the 4
r 5 years of follow-up. Schwartz et al. (13) speculate that
RS may not only act by way of susceptibility to arrhythmic
eath (and perhaps by determining long-term BP) but also
y a type of genetic “autonomic fingerprint” that is appli-
able over the longer term. Each of these studies was in
atients who were given contemporary gold standard treat-
ent; therefore, the results are applicable in today’s clinical
ontext.
These new measures have a sound pathophysiological
asis. The measurement of BRS in these studies used BP
hanges produced by injection of phenylephrine, but it is
ow possible to measure autonomic function using sponta-
eous variability of BP and pulse interval, or indexes of heart
ate variability, which may be more widely applicable.
inally, both BRS and protection against serious arrhythmia
ay be improved with exercise training (20), or by drugs
21), both of which may help long-term outcome. Vagal
one also can be increased by the slow breathing induced by
epetitive recitation of the Rosary (Ave Maria) prayer, or by
antras (22), which might be an alternative aid if bettertudied in MI survivors in future.
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